C12orf48 Activators
C12orf48, a protein with emergent scientific attention, is central to this discourse. Agents such as Forskolin and 8-Bromoadenosine cAMP, by bolstering cAMP levels, instigate the activation of protein kinase A (PKA). PKA, a key switch in cellular signaling, can impact a suite of transcriptional processes, with a potential bearing on the levels or activity of C12orf48. Another notable agent, IBMX, impedes phosphodiesterase, culminating in a surge in cAMP levels, a scenario that can indirectly mold the dynamics of C12orf48.
In addition, PMA, by igniting the PKC cascade, lays the groundwork for changes in various transcriptional activities that can intersect with the C12orf48 trajectory. The EGF pathway, set in motion by EGF, is a nexus of intricate signaling that can extend its reach to C12orf48. Anisomycin, through its engagement with the JNK pathway, and Oltipraz, by ushering the Nrf2 pathway, both bring about a flux in transcriptional landscapes. This flux, while expansive, can shape the contours of C12orf48 expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates PKA, which can modulate various transcriptional processes, indirectly affecting C12orf48 levels. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor, elevating cAMP levels. This increase can potentially alter transcriptional dynamics, possibly influencing C12orf48. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC and modifies several transcriptional events. This broad-spectrum influence can have indirect effects on proteins like C12orf48. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Triggers the JNK pathway, which impacts multiple transcriptional programs, offering potential influence on C12orf48. | ||||||
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
Stimulates the Nrf2 pathway, influencing several downstream transcription factors. This cascade can indirectly impact C12orf48. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog promoting PKA activation. The downstream effects can potentially impact C12orf48 levels. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Activates various pathways affecting transcriptional responses, which can encompass C12orf48. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore influencing calcium-mediated signaling events, offering potential modulation of C12orf48. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore modifying calcium-dependent signaling, which can extend its effects to proteins like C12orf48. | ||||||